These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Anticancer activity of osmium metalla-rectangles. Barry NP; Edafe F; Dyson PJ; Therrien B Dalton Trans; 2010 Mar; 39(11):2816-20. PubMed ID: 20200707 [TBL] [Abstract][Full Text] [Related]
6. Anticancer potency studies of coordination driven self-assembled arene–Ru-based metalla-bowls. Mishra A; Jeong YJ; Jo JH; Kang SC; Lah MS; Chi KW Chembiochem; 2014 Mar; 15(5):695-700. PubMed ID: 24677392 [TBL] [Abstract][Full Text] [Related]
7. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents. Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192 [TBL] [Abstract][Full Text] [Related]
8. Influence of the Linker Length on the Cytotoxicity of Homobinuclear Ruthenium(II) and Gold(I) Complexes. Batchelor LK; Păunescu E; Soudani M; Scopelliti R; Dyson PJ Inorg Chem; 2017 Aug; 56(16):9617-9633. PubMed ID: 28758743 [TBL] [Abstract][Full Text] [Related]
9. Self-assembled ruthenium (II) metallacycles and metallacages with imidazole-based ligands and their in vitro anticancer activity. Zhao Y; Zhang L; Li X; Shi Y; Ding R; Teng M; Zhang P; Cao C; Stang PJ Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4090-4098. PubMed ID: 30765514 [TBL] [Abstract][Full Text] [Related]
10. Similarities and differences in d Gilewska A; Barszcz B; Masternak J; Kazimierczuk K; Sitkowski J; Wietrzyk J; Turlej E J Biol Inorg Chem; 2019 Jun; 24(4):591-606. PubMed ID: 31115765 [TBL] [Abstract][Full Text] [Related]
11. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents. Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605 [TBL] [Abstract][Full Text] [Related]
12. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features. Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963 [TBL] [Abstract][Full Text] [Related]
14. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties. Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819 [TBL] [Abstract][Full Text] [Related]
15. Selective anticancer activities of ruthenium(II)-tetrazole complexes and their mechanistic insights. Sonkar C; Malviya N; Sinha N; Mukherjee A; Pakhira S; Mukhopadhyay S Biometals; 2021 Aug; 34(4):795-812. PubMed ID: 33900532 [TBL] [Abstract][Full Text] [Related]